Clinical Trials Browser

NIH × Prostatic Neoplasms × Dasatinib × Clear all

NCT01260688 2018-08-08

Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel

Phase 2 Completed

22 enrolled 23 charts

Prostatic Neoplasms